Astellas' First Domestic Prescription of XTANDI® Filled at Baiair Health Pharmacy

March 9: New Prostate Cancer Drug—Anctan^®(Generic name: Enzalutamide) The first domestic prescription for Xtandi was filled at the Dongdan North Street Branch of Beijing Baiyang Health Pharmacy (hereinafter referred to as “Baiyang Pharmacy”).^®is JapanSecond Largest Prescription Drug ManufacturerAstellas’ first oncology drug approved in China, indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic and have not received chemotherapy, following failure of androgen deprivation therapy (ADT).

Anktava Officially Launched

Anktiva Officially Launched

First Prescription

Patient Medication Pickup

Prostate cancer is the second most common malignant tumor in men worldwide and has become the most common male urological malignancy in China. Since 2012, enzalutamide has been prescribed to more than 420,000 patients globally. With Xtandi^®Approved for entry into the Chinese market, enabling tens of thousands of Chinese patients with metastatic castration-resistant prostate cancer to benefit by reducing the risk of disease progression and death. 

Astellas and Baiyang Pharmaceutical have maintained a multi-year partnership. In 2019, leveraging Baiyang Pharmaceutical’s professional pharmaceutical commercialization platform, Astellas entrusted Baiyang Pharmaceutical with the expansion of the retail market for its products, including tamsulosin hydrochloride sustained-release capsules (brand name: Harnal) and febuxostat tablets (brand name: Feburic). Building on their strong collaborative foundation and the professional capabilities of Baiyang Health Pharmacy, Astellas has now entrusted Ankangtan^®China's First Prescription Lands at Baiyang Health Pharmacy.

Baiyang Health Pharmacy, as a professional smart pharmacy, has achieved an organic integration of health management and intelligent healthcare through a new model centered on pharmaceutical care, characterized by customer experience, supported by digital marketing, and grounded in offline delivery. In terms of pharmaceutical care, Baiyang Pharmacy employs licensed pharmacists with extensive experience to provide professional pharmaceutical services and patient follow-up services. For specialized delivery, the pharmacy equips its delivery personnel with cold-chain boxes, enabling full-process temperature monitoring during transportation. Regarding its drug portfolio, Baiyang Pharmacy offers a wide range of novel specialty oncology drugs and chronic disease treatment medications, meeting patients’ needs for various types of medicines.

Guided by its mission to provide better healthcare products and services to society, Baiyang Pharmaceutical has established a commercialization “expressway.” By leveraging omnichannel management, multi-category synergy, and digital marketing capabilities, it delivers comprehensive omnichannel solutions to upstream manufacturers, enabling rapid and effective deployment of high-quality products and technologies into practical applications. As a retail channel, Baiyang Health Pharmacy will continue to enhance its professional capabilities, offering patients greater access to medications and higher-quality, more convenient services.

Pharmacy Address: 1/F, CITS Building, No. 1 Dongdan North Street, Dongcheng District, Beijing

Contact Number: 010-53398311